scispace - formally typeset
P

Pedro Carrilho-Ferreira

Researcher at University of Lisbon

Publications -  23
Citations -  360

Pedro Carrilho-Ferreira is an academic researcher from University of Lisbon. The author has contributed to research in topics: Medicine & Coronary artery disease. The author has an hindex of 9, co-authored 19 publications receiving 236 citations.

Papers
More filters
Journal ArticleDOI

Circulating miR-122-5p/miR-133b Ratio Is a Specific Early Prognostic Biomarker in Acute Myocardial Infarction.

TL;DR: This study showed that the miR-122-5p/133b ratio is a new prognostic biomarker for the early identification of STEMI patients at a higher risk of developing major adverse events after undergoing primary percutaneous coronary intervention.
Journal ArticleDOI

Coexistence and outcome of coronary artery disease in takotsubo syndrome

L. Christian Napp, +94 more
TL;DR: Coronary artery disease frequently coexists in TTS patients, presents with the whole spectrum of coronary pathology including acute coronary occlusion, and is associated with adverse outcome.
Journal ArticleDOI

Cystatin C as prognostic biomarker in ST-segment elevation acute myocardial infarction.

TL;DR: It is concluded that cystatin C is a new biomarker with significant added prognostic value for patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention, predicting both short- and long-term outcomes.
Journal ArticleDOI

Age-Related Variations in Takotsubo Syndrome

Victoria L. Cammann, +108 more
TL;DR: A substantial proportion of TTS patients are younger than 50 years of age, particularly in younger patients, and younger patients had more often cardiogenic shock and had a numerically higher in-hospital mortality compared with middle-aged and elderly T TS patients.
Journal ArticleDOI

Non-compaction Cardiomyopathy: Prevalence, Prognosis, Pathoetiology, Genetics, and Risk of Cardioembolism

TL;DR: Left ventricular non-compaction is an uncommon condition that can occur isolated or in association with other disorders, including congenital heart anomalies and mitochondrial or musculoskeletal disorders.